NCT06299605View on ClinicalTrials.gov

Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori

NAEnrolling by invitationINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

November 30, 2025

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan-Amoxicillin-Tetracycline-Bismuth quadruple regimen for 14 days

Vonoprazan 20mg bid + Amoxicillin 1000mg bid + Tetracycline 500mg qid + Bismuth 220mg bid for 14 days

DRUG

Vonoprazan-Amoxicillin-Tetracycline triple regimen for 14 days

Vonoprazan 20mg bid + Amoxicillin 1000mg bid + Tetracycline 500mg qid for 14 days

DRUG

Vonoprazan-Amoxicillin-Tetracycline triple regimen for 7 days

Vonoprazan 20mg bid + Amoxicillin 1000mg bid + Tetracycline 500mg qid for 7 days

Trial Locations (1)

250000

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

Binzhou Maternal and Child Health Hospital

UNKNOWN

collaborator

Zibo Maternal and Child Health Hospital

UNKNOWN

collaborator

Zaozhuang Municipal Hospital

OTHER

collaborator

Linyi Yizhou Hospital

UNKNOWN

collaborator

Feicheng Municipal People's Hospital

UNKNOWN

lead

Shandong University

OTHER